Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design - Gastroenterology
Multiplicity – What is it, and why is it important? - Quantics Biostatistics
Composite End Points in Clinical Research | Circulation
A study design with conditional, serially assessed coв•'primary endpoints: An application to a singleв•'arm, pilot non
Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported rando
Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ® (tofacitinib) in Subjects with Rheumatoid Arthritis (RA) | Business Wire
PDF) A multiple testing framework for diagnostic accuracy studies with co-primary endpoints
Qc in clinical trials
Impact of non‐binding FDA guidances on primary endpoint selection in Alzheimer's disease trials - Yu - 2022 - Alzheimer's & Dementia: Translational Research & Clinical Interventions - Wiley Online Library
Choosing primary endpoints for clinical trials of health care interventions - ScienceDirect
PulmCrit Wee- Secondary endpoints: Can we separate the wheat from the chaff?
Choice of Primary (or Co-primary) Endpoints: Efficacy, Safety, or Net Clinical Benefit in Superiority and Non-inferiority Trials | tctmd.com
Clinical Data | XIAFLEX® (collagenase clostridium histolyticum)
The Efficacy of XHANCE | XHANCE? (fluticasone propionate)
On Biostatistics and Clinical Trials: November 2017
Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints
Clinical Trials With Multiple Endpoints: Pitfalls And Management | Premier Consulting
Primary and Secondary Outcome Reporting in Randomized Trials: JACC State-of-the-Art Review | Journal of the American College of Cardiology
PDF) A two-stage design with two co-primary endpoints
Assessing Composite Outcomes in Clinical Trials - Students 4 Best Evidence
Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA) - Clinical and Translational ...
Sequential sample size re-estimation in clinical trials with multiple co-primary endpoints - WRAP: Warwick Research Archive Portal
The Regulatory Strategist Toolbox: Clinical Endpoint Analysis Tools | RAPS
Multiple Co-primary Endpoints: Medical and Statistical Solutions A Report From the Multiple Endpoints Expert Team of the Pharmac
The Primary Outcome Fails — What Next? | NEJM
Biohaven Announces Successful Achievement of Both Co-Primary Regulatory Endpoints in Two Pivotal Phase 3 Trials of Rimegepant an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine | Biohaven Pharmaceuticals
